慢性血小板狭窄症作为早期检测西托质血的标志物
Parth S Patel1, Sujaytha Paknikar2, Vinaya Simha2
1Department of Internal Medicine, Mayo Clinic, Rochester MN, USA (Dr Patel).
Journal of clinical lipidology
|October 16, 2025
概括
细胞血症是一种罕见的遗传性疾病,在心血管问题出现之前,可以表现为慢性血小板缺血 (血小板数量低). 早期的基因检测和以泽提治疗可以改善胆固醇水平和血小板计数.
科学领域:
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
- 血液学 血液学 血液学
背景情况:
- 胆固醇血症是一种罕见的自体复发性衰退性疾病,由于ABCG5/G8基因突变,影响植物固醇和胆固醇分泌.
- 它通常与早发性动脉样硬化心血管疾病 (ASCVD) 相关,但由于正常的脂质样本或缺乏家族病史,诊断可能具有挑战性.
- 血液学异常,包括血小板缺血,可以呈现特征.
研究的目的:
- 突出家族性血小板缺血,作为潜在的早期标志的血.
- 强调基因检测对于无法解释的慢性血小板缺血的准确诊断的重要性.
- 评估ezetimibe和饮食修改在治疗胆固醇高血症及其血液表现方面的疗效.
主要方法:
- 三个兄弟姐妹的病例报告,患有无法解释的慢性血小板缺血.
- 综合基因评估以确定ABCG5/G8基因中的突变.
- 在治疗前和治疗后对固醇配置分析和血小板计数的监测.
主要成果:
- 三个兄弟姐妹都被诊断出由于同卵同卵的ABCG5基因突变而导致的胆固醇缺乏症.
- 证实了高血醇和营醇水平的增加.
- 埃泽提米布治疗和饮食改变导致固醇水平显著降低 (40-66%),血小板数量改善 (22-39%).
结论:
- 亲属性血栓细胞减小可能是细胞胆固醇衰竭的主要症状,在ASCVD之前.
- 基因检测对于在患有无法解释的慢性血小板缺血症的患者中早期诊断质血症至关重要.
- 与饮食改变相结合的ezetimibe疗法在治疗胆固醇衰竭和改善相关的血液异常方面是有效的.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Chronic Kidney Disease II: Clinical Manifestations
547
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
547
